Incyte Board of Directors has unanimously appointed Bill Meury as President and Chief Executive Officer (CEO) and a member of ...

AGC Biologics will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama ...

As the pharmaceutical industry continues to evolve, so too does the role of secondary packaging. From serialization and ...

MAIA Biotechnology Inc., a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer ...

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred the upstream phase of the manufacturing process for LUMEVOQ, its gene ...

Silo Pharma Inc. has entered into a non-binding letter of intent to form a strategic 50:50 joint venture with Hoth ...

Bio-Thera Solutions and SteinCares have signed a new agreement to commercialize a proposed biosimilar of dupilumab across ...

Gilead Sciences Inc. and Kymera Therapeutics Inc. have entered into an exclusive option and license agreement.

GSK’s approval expands belimumab treatment options, offering a first-of-its-kind subcutaneous option that can be administered ...

Xcell Biosciences, an instrumentation company focused on cell and gene therapy applications, has partnered with Thermo Fisher ...

Amzal is a statistician, public health scientist, and entrepreneur with more than 25 years of experience across biotech and ...

The cost of a failed CDMO relationship isn’t just financial. It’s strategic. It delays clinical timelines. It erodes investor ...